Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00062387 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Head and Neck Cancer

Interventions

DRUG: perifosine

Sponsor

National Cancer Institute (NCI)